2026-07-22T20:06:08Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/93392025-04-10T11:21:30Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19613

00925njm 22002777a 4500 dc Royo-Bordonada, Miguel Angel author Armario, Pedro author Lobos Bejarano, José María author Pedro-Botet, Juan author Villar Alvarez, Fernando author Elosua, Roberto author Brotons Cuixart, Carlos author Cortés, Olga author Serrano, Benilde author Camafort Babkowski, Miguel author Gil-Núñez, Antonio author Pérez, Antonio author Maiques, Antonio author de Santiago Nocito, Ana author de Castro, Almudena author Alegría, Eduardo author Baeza, Ciro author Yuste-Herranz, Maria Eloisa author Sans, Susana author Campos, Pilar author 2017 The VI European Guidelines for Cardiovascular Prevention recommend combining population and high-risk strategies with lifestyle changes as a cornerstone of prevention, and propose the SCORE function to quantify cardiovascular risk. The guidelines highlight disease specific interventions, and conditions as women, young people and ethnic minorities. Screening for subclinical atherosclerosis with noninvasive imaging techniques is not recommended. The guidelines distinguish four risk levels (very high, high, moderate and low) with therapeutic objectives for lipid control according to risk. Diabetes mellitus confers a high risk, except for subjects with type 2 diabetes with less than <10 years of evolution, without other risk factors or complications, or type 1 diabetes of short evolution without complications. The decision to start pharmacological treatment of arterial hypertension will depend on the blood pressure level and the cardiovascular risk, taking into account the lesion of target organs. The guidelines don't recommend antiplatelet drugs in primary prevention because of the increased bleeding risk. The low adherence to the medication requires simplified therapeutic regimes and to identify and combat its causes. The guidelines highlight the responsibility of health professionals to take an active role in advocating evidence-based interventions at the population level, and propose effective interventions, at individual and population level, to promote a healthy diet, the practice of physical activity, the cessation of smoking and the protection against alcohol abuse. Gac Sanit. 2017 May - Jun;31(3):255-268. 10.1016/j.gaceta.2016.12.007 1578-1283 0213-9111 Gaceta sanitaria 28292529 http://hdl.handle.net/20.500.12105/9339 Alcohol drinking Cardiovascular diseases Cholesterol Colesterol Consumo de alcohol Diabetes mellitus Enfermedades cardiovasculares Grasas trans Guías de práctica clínica Hipertensión arterial Hypertension Practice Guidelines [Publication Type] Prevención y control Prevention and control Tabaco Tobacco Trans fatty acids Adaptación española de las guías europeas de 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica